Treatment of sanfilippo syndrome type b

作者: Bettina Strack-Logue , Michael F. Concino , Pericles Calias , Richard Pfeifer , Angela Norton

DOI:

关键词: BiologyLysosomal targetingIntrathecalBiochemistryMoietySanfilippo BMolecular biologyFusion proteinSanfilippo syndromeRecombinant DNA

摘要: Among other things, the present invention provides methods and compositions of treating Sanfilippo syndrome type B (Sanfilippo B) by, e.g., intrathecal (IT) administration a Naglu protein. A suitable protein can be recombinant, gene-activated or natural In some embodiments, is recombinant fusion containing domain lysosomal targeting moiety. an IGF-II

参考文章(34)
Martin Ph. Verbeet, Ans T. Van der Ploeg, Frank R. Pieper, Arnold J. J. Reuser, Lysosomal proteins produced in the milk of transgenic animals ,(1996)
Stephen Misener, Stephen A. Krawetz, Bioinformatics Methods and Protocols Humana Press. pp. 500- ,(1999) , 10.1385/1592591922
Denise R. Barbut, Russel H. Patterson, Mark-Hein Heinemann, Medical device for selective intrathecal spinal cooling in aortic surgery and spinal trauma ,(2000)
Hans Reichert, Peter Simmendinger, Thomas Bolle, Enzyme-based time temperature indicator ,(2005)
Pericles Calias, Richard Pfeifer, Thomas McCauley, Teresa Leah Wright, Zahra Shahrokh, Lawrence Charnas, Jan Powell, Jing Pan, Cns delivery of therapeutic agents ,(2011)